Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of combined oral hormonal contraceptive on cardiovascular health, metabolism, and weight
RBR-10c6py3jNot yet recruiting
- Sponsor
- Universidade de Gurupi
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nomegestrol and estradiol in hypertension (HTN) and obesity, sponsored by Universidade de Gurupi. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
nomegestrolestradiol
03
Conditions
hypertension (HTN)obesity
Beyond the preview
Go deeper on RBR-10c6py3j.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10c6py3j.